# zidovudine = azt = zdv

### notes
+ prescription under medical supervision

### therapeutic action
+ antiretroviral, hiv-1 and hiv-2 nucleoside reverse transcriptase inhibitor

### indications
+ hiv-1 or hiv-2 infection, in combination with other antiretroviral drugs

### presentation
+ 300 mg tablet
+ 50 mg/5 ml oral solution

### dosage
+ premature infant: 3 mg/kg/day in 2 divided doses for the first 2 weeks after birth then 8 mg/kg/day in 2 divided doses
+ child under 4 weeks: 8 mg/kg/day in 2 divided doses
+ child from 4 weeks to 13 years: 360 to 480 mg/m2/day in 2 divided doses
+ adult: 600 mg/day in 2 divided doses

| weight      | 10 mg/ml oral solution | 300 mg tablet |
|-------------|------------------------|---------------|
| 5 to 6 kg   | 6 ml x 2               | -             |
| 7 to 9 kg   | 8 ml x 2               | -             |
| 10 to 14 kg | 12 ml x 2              | -             |
| 15 to 19 kg | 17 ml x 2              | -             |
| 20 to 24 kg | 20 ml x 2              | -             |
| 25 to 29 kg | 25 ml x 2              | 1 tab x 2     |
| 30 to 39 kg | 28 ml x 2              | 1 tab x 2     |
| ≥ 40 kg     | -                      | 1 tab x 2     |

### duration
+ the duration of treatment depends on the efficacy and tolerance of zidovudine.

### contra-indications, adverse effects, precautions
+ do not administer to patients with severe haematological disorders (leukopenia, anaemia), to neonates with hyperbilirubinaemia or raised transaminases.
+ may cause: haematological disorders (monitor cbc), gastrointestinal disturbances (nausea, diarrhoea, etc.), headache, myopathy, hepatic disorders, lactic acidosis. stop taking zidovudine in the event of severe haematological disorders or hepatic disorders (hepatomegaly, raised transaminases).
+ reduce dosage in patients with severe renal or hepatic impairment.
+ *pregnancy*: no contra-indication

### remarks
+ for prophylactic treatment to reduce mother-to-child transmission, check national recommendations.
+ many fixed-dose combinations containing zidovudine are available.
+ storage: below 25°c